Drivers determining active TB screening yield in different European screening programmes: a comparative analysis.
D. Zenner (London, United Kingdom), D. Brals (Amsterdam, Netherlands), C. Erkens (The Hague, Netherlands), A. Matteeli (Brescia, Italy), J. Nederby Öhd (Stockholm, Sweden), D. Menezes (London, United Kingdom), G. De Vries (Bilthoven, Netherlands), M. Muzyamba (London, United Kingdom), J. Van Rest (The Hague, Netherlands), V. Marchese (Brescia, Italy), R. Aldridge (London, United Kingdom), I. Spruijt (The Hague, Netherlands), J. Were (London, United Kingdom), S. Anderson (London, United Kingdom), K. Lönnroth (Stockholm, Sweden), I. Abubakar (London, United Kingdom), F. Cobelens (Amsterdam, Netherlands)
Source: International Congress 2022 – Advances in epidemiology, diagnosis and treatment of tuberculosis
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Zenner (London, United Kingdom), D. Brals (Amsterdam, Netherlands), C. Erkens (The Hague, Netherlands), A. Matteeli (Brescia, Italy), J. Nederby Öhd (Stockholm, Sweden), D. Menezes (London, United Kingdom), G. De Vries (Bilthoven, Netherlands), M. Muzyamba (London, United Kingdom), J. Van Rest (The Hague, Netherlands), V. Marchese (Brescia, Italy), R. Aldridge (London, United Kingdom), I. Spruijt (The Hague, Netherlands), J. Were (London, United Kingdom), S. Anderson (London, United Kingdom), K. Lönnroth (Stockholm, Sweden), I. Abubakar (London, United Kingdom), F. Cobelens (Amsterdam, Netherlands). Drivers determining active TB screening yield in different European screening programmes: a comparative analysis.. 763
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|